Quidel is a leading supplier for complement pathway markers as well as for bone resorption and bone formation markers.
Quidel has developed several enzyme-linked immunoassays that allow assessment of complement status and can be used to perform clinical as well as preclinical studies.
With these assays, standardized tests can be performed with the aim to develop better biocompatible materials with minimal complement-activation potential.
- Complement proteins
- Complement depleted sera
- ELISA assays for complement antigens
- Complement reagents
- Complement antibodies
Link to Quidel